-
Uncategorized2 months ago
STRAIGHT-IN Dual: a platform for dual single-copy integrations of DNA payloads and gene circuits into human induced pluripotent stem cells
Post Content
-
Uncategorized2 months ago
Tracing the rise of biomedical foundation models
Nature Biotechnology, Published online: 30 April 2026; doi:10.1038/s41587-026-03135-y A survey of biological foundation models reveals current trends and provides an outlook for future developments in this...
-
Uncategorized2 months agoSTAT+: Supreme Court justices appear to signal ‘skinny labeling’ can survive
After months of anticipation, Supreme Court justices heard arguments about a long-standing tactic used by generic companies to carve out a distinct market for a medicine,...
-
Uncategorized2 months ago
AbbVie faces questions about Skyrizi competition from J&J
Threats to AbbVie’s immunology dominance took center stage on the company’s first-quarter earnings call Wednesday morning, as analysts pressed executives on their defense strategy. The heart...
-
Uncategorized2 months ago
AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate
Strong growth in immunology and neurology prompted AbbVie to raise its 2026 outlook and consider future M&A from a position of “ample financial capacity.”
-
Uncategorized2 months ago“Click Clotting” Technique Rapidly Creates Stronger Blood Clots
Researchers at McGill University have developed a rapid way to engineer blood clots that stop severe bleeding and support tissue healing more effectively. Their technique, called...
-
Uncategorized2 months agoSTAT+: Why conversations around health AI may be evolving beyond hype
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
Uncategorized2 months ago
Supply Chain Digital Twins: An Evolution, Not a Breakthrough
Digital twins help optimize drug production processes by modeling the thousands of interactions that cells, raw materials, and reagents undergo in culture. And new analysis suggests...
-
Uncategorized2 months agoTeva nabs experimental Tourette drug in $700M Emalex buyout
A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes sense” given the synergies between Emalex and the pharmaceutical giant’s neurology business.
-
Uncategorized2 months ago
Loss of Smell Therapies Informed by Olfactory Receptor Spatial Mapping
A new study published in Cell titled, “A spatial code governs olfactory receptor choice and aligns sensory maps in the nose and brain,” led by researchers from Harvard...
